Maintenance treatment with H2 receptor antagonists in patients with peptic ulcer disease: rarely justified in terms of cost or patient benefit.
- 26 November 1988
- Vol. 297 (6660) , 1393-1394
- https://doi.org/10.1136/bmj.297.6660.1393
Abstract
Maintenance treatment reduces the frequency of ulcer relapse. Its routine use is unnecessary because the condition is benign and most patients do not relapse frequently. Routine maintenance treatment does not reduce the incidence of complications of ulcers overall, although it may do so in specific groups mentioned above. Routine maintenance treatment for all patients with ulcers would be expensive as well as largely unnecessary.Keywords
This publication has 18 references indexed in Scilit:
- The treatment of gastric ulcer with antisecretory drugsDigestive Diseases and Sciences, 1988
- Long term management of duodenal ulcer in general practice: How best to use cimetidine?BMJ, 1988
- Acid suppression in duodenal ulcer: a meta-analysis to define optimal dosing with antisecretory drugs.Gut, 1987
- NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLEEDING PEPTIC ULCERThe Lancet, 1986
- RISING FREQUENCY OF ULCER PERFORATION IN ELDERLY PEOPLE IN THE UNITED KINGDOMThe Lancet, 1986
- Comparison of different strategies for treatment of duodenal ulcer.BMJ, 1985
- Natural History of Duodenal UlcerDigestive Diseases, 1985
- Cimetidine, Cigarette Smoking, and Recurrence of Duodenal UlcerNew England Journal of Medicine, 1984
- RANITIDINE AND CIMETIDINE IN PREVENTION OF DUODENAL ULCER RELAPSE *1A Double-blind, Randomised, Multicentre, Comparative TrialThe Lancet, 1984
- Peptic Ulcer: A profileBMJ, 1964